About Cypex
Cypex is a Healthcare company based in Dundee (United Kingdom) founded in 1998, and was acquired by BioIVT in August 2022. Company offering in vitro drug metabolism services using their patented technology for producing recombinant cytochrome P450 in bacteria. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Assays and Drug Discovery. Its competitors include Metrion Biosciences and Clyde Biosciences; 2 of its 2 listed competitors have raised funding.
Company details
Cypex offers products and services for studying in vitro drug metabolism. Founded based on the technology for manufacturing recombinant drug-metabolising enzymes cytochrome P450 in bacteria, which was developed at the University of Dundee and funded by the UK Research Council (BBSRC) and a consortium of pharmaceutical companies, Cypex offers its products and services to pharma and biotech companies and CROs for studying the metabolism of products under investigation. The companys core product portfolio includes human, rodent, dog and monkey CYP enzymes, as well as allelic variants, and other human metabolising enzymes. They also offer CYP substrates, inhibitors, and antibodies. They offer their products in the form of bactosomes which are bacterial membranes containing human cytochrome P450s coexpressed with human NADPH-cytochrome P450 reductase. Cypex also offers fluorimetry based assays to determine the CYP inhibition potential of novel compounds using bactosomes as the enzyme source.
- Headquarters Dundee, United Kingdom
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website cypex.co.uk
- Social LinkedIn
- Acquired by BioIVT (Aug 2022)
Investors in Cypex
Cypex has secured backing from 1 investor. Prominent investors backing the company include BioIVT.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of in vitro diagnostic products and assay services | 2015 | bioivt.com | Westbury, United States |
Investor details for Cypex
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Cypex
2 dated milestones of Cypex across 24 years, from founding to its latest funding, stage changes and deals.
- Founded Cypex is founded.
- Exit Acquired by BioIVT.
Competitors of Cypex
Cypex has 2 listed competitors in our database, 2 of them funded. They include Metrion Biosciences and Clyde Biosciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| metrionbiosciences.com | 2015 | Cambridge, United Kingdom | $8.44M | Ion channel screening and cardiac safety profiling services are provided. | ||
| clydebio.com | 2012 | Holytown, United Kingdom | $3.5M | 6 | Cardiac safety testing is conducted using iPS-derived heart cells. |
Detailed competitors of Cypex
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cypex
Websites that share an audience with Cypex (cypex.co.uk).
Websites whose visitors overlap most with Cypex. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
mediprotrans.de | mediprotrans.de | 100% | – | ||
| pro-lab.com | 100% | #3,610,074 | View details | ||
intergenco.com | intergenco.com | 100% | – | ||
dutch-diagnostics.com | dutch-diagnostics.com | 100% | – | ||
| artronbio.com | 100% | #14,665,950 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 19 similar websites and full traffic analytics for Cypex
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 19 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Cypex (Life Sciences Platforms & Tools) in United Kingdom, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | |||
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cypex
Complete news archive for Cypex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cypex
Cypex was founded in 1998.
Cypex is headquartered in Dundee, United Kingdom. It is registered at Dundee, Scotland, United Kingdom.
Cypex offers products and services for studying in vitro drug metabolism. Founded based on the technology for manufacturing recombinant drug-metabolising enzymes cytochrome P450 in bacteria, which was developed at the University of Dundee and funded by the UK Research Council (BBSRC) and a consortium of pharmaceutical companies, Cypex offers its products and services to pharma and biotech companies and CROs for studying the metabolism of products under investigation. The companys core product portfolio includes human, rodent, dog and monkey CYP enzymes, as well as allelic variants, and other human metabolising enzymes. They also offer CYP substrates, inhibitors, and antibodies. They offer their products in the form of bactosomes which are bacterial membranes containing human cytochrome P450s coexpressed with human NADPH-cytochrome P450 reductase. Cypex also offers fluorimetry based assays to determine the CYP inhibition potential of novel compounds using bactosomes as the enzyme source.
Cypex's top competitors include Metrion Biosciences and Clyde Biosciences.
Cypex has 1 investor. Key investors include BioIVT.
Yes. Cypex was acquired by BioIVT in August 2022.